Expression of CD3, PD-L1 and CTLA-4 in mammary and extra-mammary Paget disease.

Georgia KarpathiouCeline ChauleurSirine HathroubiCyril HabougitMichel Peoc'h

Published in: Cancer immunology, immunotherapy : CII (2018)

Paget disease is characterized by an intense lymphocytic response, devoid of the immune-suppressive impact of the PD-L1 pathway, but with occasional CTLA-4 expression.

Keyphrases

poor prognosis
binding protein
long non coding rna
nk cells